CG
Coleen Glessner (EVP, Quality & Ethics, and CPL) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale, 1 filed past the two-business-day deadline), most often in Emergent BioSolutions Inc. (EBS). The largest single filing was $306K of EBS (30,608 sh × $10.00, as filed), executed Oct 7 2025. Data as of Nov 7 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells · 1 late
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$306K
shares × price, as filed
Last traded
Oct 7 2025
Filed Oct 16 2025
Median ADV $8.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $306K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
EBS
Emergent BioSolutions Inc.
EBS · 0 buys · 1 sell
1 filing
Recent filings
EBSSALE
Emergent BioSolutions Inc.
View filing →
$306K30,608 sh × $10.00
Exec Oct 7 2025
Filed Oct 16 2025 · 5:30 PM ET †